Pediatric Trials Network Long-term Antipsychotic Pediatric Safety Trial (LAPS) NICHD-2016-LAP01 Phase 4 Trial
Phase of Trial: Phase IV
Latest Information Update: 29 Nov 2019
Price : $35 *
At a glance
- Drugs Aripiprazole (Primary) ; Risperidone (Primary)
- Indications Autistic disorder; Bipolar disorders; Schizophrenia
- Focus Adverse reactions
- Acronyms LAPS
- 26 Nov 2019 Planned End Date changed from 1 Sep 2021 to 1 Jul 2021.
- 26 Nov 2019 Planned primary completion date changed from 1 Sep 2021 to 1 Jul 2021.
- 08 Jan 2019 Status changed from not yet recruiting to recruiting.